Please Wait
Applying Filters...
menu
    • menu
    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Indacaterol

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 203,185Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    11/10/2024 Inke S.A
    Spain
    		 Samoh Pharmaceutical Co., Ltd. Su207-45-ND Indacaterol Maleate 2020-10-27 INKE SA Spain 08755 Area Industrial del Llobregat, C/Argent 1, Castellbisbal Barcelona, ​​Spain
    28/09/2024 Novartis Pharmaceuticals Corporation
    Switzerland
    		 Novartis Korea Ltd. 196-27-ND Indacaterol maleate 2024-01-29 Novartis Pharma Schweizerhalle AG@Novartis Pharma AG@Novartis Pharma Stein AG@Sterling Pharma Ringaskiddy Limited@Novartis Pharmaceutical Manufacturing LLC Switzerland Rothausstrasse, 4133, Pratteln, Switzerland@Lichstrasse 35 4056 Basel, Switzerland @Schaffhausertrasse 4332 Stein, Switzerland@Ringaskiddy, Co. Cork, P43 FR63, Ireland@Kolodvorska Cesta 27, Menges, 1234, Slovenia